International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS)


At a Glance
  • Status: Active Consortium
  • Year Launched: 2001
  • Initiating Organization: Drinker Biddle & Reath LLP
  • Initiator Type: Industry
  • No disease focus
  • Location: International

Abstract

IPAC-RS is an international association that seeks to advance the science, and especially the regulatory science, of orally inhaled and nasal drug products (OINDP) by collecting and analyzing data, and conducting joint research and development projects. Members include innovator and generic companies that develop, manufacture or market orally inhaled and nasal drug products for local and systemic treatment of a variety of debilitating diseases such as asthma, chronic obstructive pulmonary disease, and diabetes.

Mission

IPAC-RS aims to build consensus and contribute to effective regulations and standards by sharing the results of our research through conferences, technical journals, and discussions with regulatory bodies. IPAC-RS represents the interests of its members to international authorities and standard-setting bodies (such as the FDA). IPAC-RS’ mission is to enhance the quality and availability to patients of orally inhaled and nasal drug products (OINDP) through scientifically driven advancements related to development and regulation of these products.

Consortium History

IPAC-RS was formed as part of the International Pharmaceutical Aerosol Consortium (IPAC) in 1999 and established in 2001 as a separate Consortium.

For a timeline of the Consortium’s growth, click here

Structure & Governance

The consortium is governed by the Board of Directors, which is comprised of representatives from each member company.  They oversee four strategic initiatives within the IPAC-RS work stream.

Financing

The Consortium is governed by the Board of Directors, which is comprised of representatives from each member company.  They oversee five strategic initiatives within the IPAC-RS work stream.   

Intellectual Property

All images and information contained on the IPAC-RS website are copyrighted and otherwise proprietary.  Unless otherwise indicated, all logos, designs, and marks on this website are trademarks or service marks owned or used under license by IPAC-RS. 

Impact/Accomplishment

For links to news and events of IPAC-RS, click here

Points of Contact

To contact IPAC-RS, click here

Sponsors & Partners

3M

Actavis

AstraZeneca

Boehringer Ingelheim

Catalent

Chiesi

GlaxoSmithKline

Hovione

Lupin Pharmaceuticals, Inc.

Merk & Co., Inc.

Mundipharma

Mylan

Novartis

Sunovion

Teva

Vectura Ltd.


Last Updated: 06/21/2017

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.